Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 920 of 1,261
  1. US 8192991

    Methods of eliciting or boosting a cellular immune response

    The Regents of the University of California · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  2. US 8193204

    Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1- (4-chloro-2-(3-methyl-1H-pyrazol-1-YL)phenyl)2,2,2-trifluoroethoxy)-pyrimidin-4-YL)phenyl)propanoate and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  3. US 8193151

    Methods for treating atrial or ventricular arrhythmias

    Northwestern University · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  4. US 8193194

    Ion channel modulators and methods of use

    Vertex Pharmaceuticals Incorporated · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  5. US 8193152

    Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds

    The Board of Regents of the University of Texas System · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  6. US 8193330

    Polynucleotides comprising Neurogenin3 promoter and bHLH encoding domains

    The Regents of the University of California · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  7. US 8193312

    Bone morphogenic protein binding peptide

    The Regents of the University of California · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  8. US 8193339

    Synthesis of β-nucleosides

    PHARMAESSENTIA CORPORATION · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  9. US 8193357

    Androgen receptor modulator compounds

    Ligand Pharmaceuticals Incorporated · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  10. US 8187708

    Microphasic micro-components and methods for controlling morphology via electrified jetting

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 29, 2012 · Expires May 24, 2032

    granted
  11. US 8188275

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 29, 2012 · Expires May 24, 2032

    granted
  12. US 8188134

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  13. US 8188076

    Compositions, synthesis, and methods of utilizing arylpiperazine derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  14. US 8187817

    Diagnosis, treatment, and prevention of vascular disorders using IL-1 autoantibodies

    XBIOTECH INC. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  15. US 8188294

    Process for preparing biphenyl imidazole compounds

    Theravance, Inc. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  16. US 8188289

    Conformationally restricted urea inhibitors of soluble epoxide hydrolase

    The Regents of the University of California · Granted May 29, 2012 · Expires May 24, 2032

    granted
  17. US 8188283

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  18. US 8188276

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  19. US 8188221

    Peptide homing to brain tumors

    The Regents of the University of California, UCSF · Granted May 29, 2012 · Expires May 24, 2032

    granted
  20. US 8188219

    Bone morphogenic protein binding peptide

    The Regents of the University of California · Granted May 29, 2012 · Expires May 24, 2032

    granted
  21. US 8188132

    Linked dibenzimidazole derivatives

    Enanta Pharmaceuticals, Inc. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  22. US 8188096

    Protein kinase targeted therapeutics

    Northwestern University · Granted May 29, 2012 · Expires May 24, 2032

    granted
  23. US 8188095

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  24. US 8188214

    Brachyury polypeptides and methods for use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 29, 2012 · Expires May 24, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.